A phase II study of cisplatin with TS-1 for patients with cancer of primary unknown

UMIN ID: C000000271

Registered date:31/10/2005

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: cancer of primary unknown
• Date of first enrollment: 2005/10/01
• Target sample size: 45
• Countries of recruitment: Japan
• Study type: Interventional
• Intervention(s): Chemotherapy

Outcome(s)

• Primary Outcome: Response Rate
• Secondary Outcome: Safety Profile

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: 99years-old
• Gender: Male and Female
• Exclude criteria: The exclusion criteria are as follows: 1.female adenocarcinoma with axillary lymph nodes swelling only, or pelvic cavity endolymph nodes only 2.squamous carcinoma with cervical lymph nodes swelling only, or inguen lymph nodes only 3.patients with germ cell tumor or have characteristic of neuroendocrine tumor 4.patients with high level of PSA in serum or tumor (1) severe infection or other severe complications (such as gastrointestinal bleeding, heart disease) (2) symptomatic brain metastasis (3) patients who carried out bone marrow transplantation (4) patients who carried out peripheral blood stem cell transplantation (5) drug allergy (6) pregnancy or lactating (7) male patients who hope for pregnancy (8) uncontrollable diabetes mellitus

Related Information

• Primary Sponsor: Department of Medical Oncology, Kinki University School of Medicine
• Source(s) of Monetary Support: Department of Medical Oncology, Kinki University School of Medicine